Impact of aromatherapy on levels of anxiety, pain and maternal-fetal physiological parameters in pregnant women: AromaGest study

Not Applicable

• Conditions: Antenatal anxiety; Antenatal pain; Mental Health - Anxiety; Alternative and Complementary Medicine - Other alternative and complementary medicine; Reproductive Health and Childbirth - Antenatal care

• Registration Number: ACTRN12622001000796
• Lead Sponsor: Hospital Rafael Mendez

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-15
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 182

Inclusion Criteria

(1) pregnant women of legal age
(2) nulliparous
(3) term pregnancy
(4) without comorbidities (gestational diabetes, eclampsia, preeclampsia, COPD)
(5) low-risk singleton pregnancy
(6) cephalic presentation
(7) vaginal delivery.

Exclusion Criteria

(1) obstetric or medical complications of pregnancy that prevented vaginal delivery
(2) maternal smell problems
(3) multiple gestations
(4) women with mental health problems
(5) who do not want to voluntarily participate in the study .

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain: The Visual Analog Scale (VAS)[Pain: immediately before and after aromatherapy is administered];Change in pregnant women's anxiety levels during cardiac-fetal monitoring and the start of the labor dilatation period, measured by State-Trait Anxiety Inventory (STAI) test, before starting it and after finish it, on interventional group and control group.[Cardiac-fetal monitoring session: immediately before and after aromatherapy is administered<br>Labor dilatation period: immediately before and after aromatherapy is administered]